Jakub Hlávka

Biosimilar Cost Savings in the United States: Initial Experience and Future Potential

Andrew Mulcahy, Jakub Hlávka, Spencer Case · RAND Corporation eBooks · 2017 · 199 citations · Full text

Preclinical Therapeutics, Patent Prosecution, Biologics Price Competition +26

Assessing the Preparedness of the Health Care System Infrastructure in Six European Countries for an Alzheimer's Treatment

Jakub Hlávka, Soeren Mattke, Jodi Liu · RAND Corporation eBooks · 2018 · 131 citations · Full text

European Union Countries, Geriatric Medicine, Primary Care +24

Macroeconomic consequences of the COVID-19 pandemic

Terrie Walmsley, Adam Rose, Richard S. John et al. · Economic Modelling · 2022 · 75 citations · Full text

Economics, Macroeconomics, Global Health Crisis +5

Blood‐based biomarkers for Alzheimer's pathology and the diagnostic process for a disease‐modifying treatment: Projecting the impact on the cost and wait times

Soeren Mattke, Sang Kyu Cho, Tobias Bittner et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2020 · 67 citations · Full text

Toward a Sustainable Blood Supply in the United States

Andrew Mulcahy, Kandice A. Kapinos, Brian Briscombe et al. · 2016 · 26 citations

Preventive Medicine, Health Policy, Transfusion Medicine +5